ACIP votes to not recommend combined MMRV shot for kids under 4news2025-09-18T13:44:53+00:00September 18th, 2025|Endpoints News|
Leadership changes at Avid Bio and Charles River; Merck KGaA opens €150M Irish sitenews2025-09-18T13:30:05+00:00September 18th, 2025|Endpoints News|
Acadia delays UK drug launch plans due to high market entry barrier for biotechsnews2025-09-18T12:40:30+00:00September 18th, 2025|Endpoints News|
Life sciences VC firm, with Bob Langer as chair, closes $77M inaugural fundnews2025-09-18T12:00:28+00:00September 18th, 2025|Endpoints News|
A Blue Shield of California spinout aims to upgrade health plan’s technews2025-09-18T12:00:04+00:00September 18th, 2025|Endpoints News|
Roche to enter FGF21 space with $2.4B buyout of MASH biotech 89bionews2025-09-18T11:02:16+00:00September 18th, 2025|Endpoints News|
#EASD25: Lilly seeks Mounjaro approval for children with diabetes following Phase 3 hitnews2025-09-18T10:41:47+00:00September 18th, 2025|Endpoints News|
A new use for a very old drug: Aspirin cut risk of recurrence for some types of colorectal cancer in half news2025-09-18T08:55:09+00:00September 18th, 2025|Endpoints News|
ArsenalBio, a well-funded cell therapy startup, halves workforce to focus resourcesnews2025-09-18T02:55:31+00:00September 18th, 2025|Endpoints News|
A patchwork effort is trying to fill CDC’s vaccine voidnews2025-09-17T22:25:11+00:00September 17th, 2025|Endpoints News|
